Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 75   

Articles published

ARNA 4.17 -0.01 (-0.24%)
price chart
Will Belviq Advertising Pick Up Again?
The month of October has passed, and with that it is time to update on what has been happening on the advertising front with Belviq from Arena (NASDAQ:ARNA). Eight weeks ago the advertising for Belviq began running at a very impressive rate. Over the ...
Lorcaserin HCl Data to be Presented at the Annual Meeting of the American ...  DigitalJournal.com
Related articles »  
Trader's Buzz: Unilife Corporation (UNIS), Arena Pharmaceuticals (ARNA ...
Arena Pharmaceuticals, Inc. (ARNA) today announced positive top-line results of a pilot study to assess the safety of lorcaserin HCl and phentermine HCl.
Biopharma Stocks Grabbing Attraction : Ariad Pharmaceuticals, Inc. (NASDAQ ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) revealed that the firm is planned to deliver a corporate summary and inform at the Credit Suisse 2014 Healthcare Conference on Wednesday, November 12, 2014, at 3:00 p.m.
Related articles »  
Corrections in Focus - Fifth Third Bancorp (FITB), Arena Pharmaceuticals, Inc ...
Miami, Florida - Nov20, 2014 - (Tech Sonian) �Fifth Third Bancorp (NASDAQ:FITB)'s homeowner reemployment program, in which it helps unemployed consumers find jobs and regain financial stability, was named a winner of the BAI-Finacle Global Banking ...
Closing Bell Actives: Las Vegas Sands Corp. (LVS), The Bank of New York ...  WallStreet Scope
Related articles »  
Morning Fast Movers: Hess Corporation (HES), Arena Pharmaceuticals, Inc ...
Arena Pharmaceuticals, Inc. (ARNA) of the Healthcare sector (Biotechnology) has lost -0.47% per share early this morning.
Related articles »  
Considerable Mover: Accenture plc (NYSE:ACN), Arena Pharmaceuticals, Inc ...
Eisai (ESALY) and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) released that data from the Phase 3 clinical trial program for lorcaserin HCl will be obtainable at the Annual Meeting of the American Association for the Study of Liver Diseases, also known ...
Latest Developments: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Novavax ...  Market News Call
Related articles »  
Morning Investor Watch: Arena Pharmaceuticals, Inc. (ARNA), Hewlett-Packard ...
Arena Pharmaceuticals, Inc. (ARNA) of the Healthcare sector has a change from open of 0.000% since the opening bell today with a volume of 277,364 shares.
Related articles »  
Morning Stock Alert: American International Group, Inc. (AIG), Arena ...
Arena Pharmaceuticals, Inc. (ARNA) of the Healthcare sector (Biotechnology) has lost $-0.019 per share early this morning.
Active Stocks to Watch: Arena Pharmaceuticals (NASDAQ:ARNA), Southwest ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) on Nov. 3 reported a third-quarter loss of $10.7 million. The company had a loss of 5 cents per share.
Related articles »  
Pharma Stocks in the News: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported that for Q3 ended Sept. 30, 2014, its loss was narrower than expected, while revenue fell short of analysts' forecasts, despite improving 128% year over year.
Related articles »